CEACAM5 and colorectal cancer: In conclusion, NLR, PNI, D-D, CD3+ T, and CEA are all potential biomarkers for screening colorectal cancer, and the combined application of these five markers in the clinical screening of colorectal cancer has high diagnostic value and can play the role of complementary advantages and mutual correction to improve the overall screening accuracy of colorectal cancer.